nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—MT3—nervous system—Gilles de la Tourette syndrome	0.0232	0.0576	CbGeAlD
Prazosin—KCNH7—nervous system—Gilles de la Tourette syndrome	0.0232	0.0576	CbGeAlD
Prazosin—MT3—central nervous system—Gilles de la Tourette syndrome	0.0223	0.0554	CbGeAlD
Prazosin—KCNH7—central nervous system—Gilles de la Tourette syndrome	0.0223	0.0554	CbGeAlD
Prazosin—MT3—brain—Gilles de la Tourette syndrome	0.0177	0.044	CbGeAlD
Prazosin—KCNH7—brain—Gilles de la Tourette syndrome	0.0177	0.044	CbGeAlD
Prazosin—KCNH6—nervous system—Gilles de la Tourette syndrome	0.0165	0.041	CbGeAlD
Prazosin—KCNH6—central nervous system—Gilles de la Tourette syndrome	0.0159	0.0395	CbGeAlD
Prazosin—KCNH6—brain—Gilles de la Tourette syndrome	0.0126	0.0314	CbGeAlD
Prazosin—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00935	0.0232	CbGeAlD
Prazosin—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.00915	0.0227	CbGeAlD
Prazosin—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.00901	0.0224	CbGeAlD
Prazosin—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.00881	0.0219	CbGeAlD
Prazosin—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00832	0.0207	CbGeAlD
Prazosin—ORM1—nervous system—Gilles de la Tourette syndrome	0.00754	0.0187	CbGeAlD
Prazosin—ORM1—central nervous system—Gilles de la Tourette syndrome	0.00726	0.018	CbGeAlD
Prazosin—ADRA1B—brain—Gilles de la Tourette syndrome	0.00715	0.0178	CbGeAlD
Prazosin—ADRA1D—brain—Gilles de la Tourette syndrome	0.00699	0.0174	CbGeAlD
Prazosin—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00694	0.0172	CbGeAlD
Prazosin—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.0069	0.0171	CbGeAlD
Prazosin—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00684	0.017	CbGeAlD
Prazosin—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.00665	0.0165	CbGeAlD
Prazosin—SLC22A3—nervous system—Gilles de la Tourette syndrome	0.0066	0.0164	CbGeAlD
Prazosin—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00659	0.0164	CbGeAlD
Prazosin—SLC22A3—central nervous system—Gilles de la Tourette syndrome	0.00635	0.0158	CbGeAlD
Prazosin—KCNH2—midbrain—Gilles de la Tourette syndrome	0.00617	0.0153	CbGeAlD
Prazosin—HTR1A—nervous system—Gilles de la Tourette syndrome	0.0057	0.0142	CbGeAlD
Prazosin—ABCG2—midbrain—Gilles de la Tourette syndrome	0.00549	0.0136	CbGeAlD
Prazosin—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.00549	0.0136	CbGeAlD
Prazosin—SLC22A1—brain—Gilles de la Tourette syndrome	0.00528	0.0131	CbGeAlD
Prazosin—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00526	0.0131	CbGeAlD
Prazosin—HTR1D—brain—Gilles de la Tourette syndrome	0.00523	0.013	CbGeAlD
Prazosin—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00519	0.00868	CbGpPWpGaD
Prazosin—ADRA2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00518	0.00868	CbGpPWpGaD
Prazosin—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00516	0.00863	CbGpPWpGaD
Prazosin—KCNH2—nervous system—Gilles de la Tourette syndrome	0.00508	0.0126	CbGeAlD
Prazosin—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00506	0.0126	CbGeAlD
Prazosin—SLC22A3—brain—Gilles de la Tourette syndrome	0.00504	0.0125	CbGeAlD
Prazosin—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00504	0.00843	CbGpPWpGaD
Prazosin—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.005	0.00838	CbGpPWpGaD
Prazosin—KCNH7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00492	0.00824	CbGpPWpGaD
Prazosin—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00491	0.00822	CbGpPWpGaD
Prazosin—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.00489	0.0121	CbGeAlD
Prazosin—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.00486	0.0121	CbGeAlD
Prazosin—ADRA2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00483	0.00808	CbGpPWpGaD
Prazosin—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00482	0.00807	CbGpPWpGaD
Prazosin—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00477	0.00798	CbGpPWpGaD
Prazosin—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00469	0.00785	CbGpPWpGaD
Prazosin—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00468	0.00783	CbGpPWpGaD
Prazosin—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00466	0.0078	CbGpPWpGaD
Prazosin—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00446	0.00746	CbGpPWpGaD
Prazosin—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00444	0.00743	CbGpPWpGaD
Prazosin—HTR1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00438	0.00733	CbGpPWpGaD
Prazosin—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00436	0.0073	CbGpPWpGaD
Prazosin—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00436	0.0073	CbGpPWpGaD
Prazosin—HTR1A—brain—Gilles de la Tourette syndrome	0.00436	0.0108	CbGeAlD
Prazosin—KCNH6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00432	0.00723	CbGpPWpGaD
Prazosin—CYP1A1—nervous system—Gilles de la Tourette syndrome	0.00429	0.0107	CbGeAlD
Prazosin—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00423	0.00709	CbGpPWpGaD
Prazosin—CYP1A1—central nervous system—Gilles de la Tourette syndrome	0.00413	0.0103	CbGeAlD
Prazosin—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00405	0.00678	CbGpPWpGaD
Prazosin—ADRA2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00402	0.00674	CbGpPWpGaD
Prazosin—ADRA1A—brain—Gilles de la Tourette syndrome	0.00402	0.00998	CbGeAlD
Prazosin—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.004	0.00993	CbGeAlD
Prazosin—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00394	0.0066	CbGpPWpGaD
Prazosin—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00393	0.00658	CbGpPWpGaD
Prazosin—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00388	0.0065	CbGpPWpGaD
Prazosin—KCNH2—brain—Gilles de la Tourette syndrome	0.00388	0.00964	CbGeAlD
Prazosin—KCNH7—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00385	0.00645	CbGpPWpGaD
Prazosin—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.00385	0.00956	CbGeAlD
Prazosin—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00378	0.00632	CbGpPWpGaD
Prazosin—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00375	0.00627	CbGpPWpGaD
Prazosin—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0037	0.00619	CbGpPWpGaD
Prazosin—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00366	0.00613	CbGpPWpGaD
Prazosin—ABCG2—brain—Gilles de la Tourette syndrome	0.00345	0.00857	CbGeAlD
Prazosin—ADRA2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00338	0.00566	CbGpPWpGaD
Prazosin—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00329	0.0055	CbGpPWpGaD
Prazosin—CYP1A1—brain—Gilles de la Tourette syndrome	0.00328	0.00814	CbGeAlD
Prazosin—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00327	0.00547	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00313	0.00523	CbGpPWpGaD
Prazosin—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00311	0.0052	CbGpPWpGaD
Prazosin—ADRA2A—brain—Gilles de la Tourette syndrome	0.00305	0.00759	CbGeAlD
Prazosin—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00305	0.00511	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00303	0.00508	CbGpPWpGaD
Prazosin—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00276	0.00462	CbGpPWpGaD
Prazosin—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00271	0.00673	CbGeAlD
Prazosin—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00257	0.0043	CbGpPWpGaD
Prazosin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00237	0.00397	CbGpPWpGaD
Prazosin—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00223	0.00553	CbGeAlD
Prazosin—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00221	0.0037	CbGpPWpGaD
Prazosin—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.00214	0.00533	CbGeAlD
Prazosin—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00198	0.00331	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00179	0.00299	CbGpPWpGaD
Prazosin—SLC22A3—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00172	0.00287	CbGpPWpGaD
Prazosin—HTR1D—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00171	0.00286	CbGpPWpGaD
Prazosin—ABCB1—brain—Gilles de la Tourette syndrome	0.0017	0.00423	CbGeAlD
Prazosin—HTR1D—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00166	0.00278	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00163	0.00273	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00159	0.00266	CbGpPWpGaD
Prazosin—HTR1D—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00155	0.00259	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00154	0.00258	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00143	0.0024	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00136	0.00228	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00136	0.00227	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00133	0.00222	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00132	0.00221	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00132	0.00221	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00132	0.00221	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00128	0.00215	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00128	0.00213	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00124	0.00207	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00124	0.00207	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00123	0.00206	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00123	0.00206	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00123	0.00205	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00119	0.002	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00119	0.00199	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00118	0.00198	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00117	0.00197	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00116	0.00195	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00115	0.00193	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00115	0.00192	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00113	0.00189	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00113	0.00189	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00112	0.00188	CbGpPWpGaD
Prazosin—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00186	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00111	0.00186	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00109	0.00183	CbGpPWpGaD
Prazosin—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00108	0.0018	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00107	0.00179	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00105	0.00176	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00105	0.00176	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00104	0.00173	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00102	0.00171	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00102	0.00171	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00102	0.0017	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00101	0.0017	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00168	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.001	0.00168	CbGpPWpGaD
Prazosin—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.001	0.00168	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.001	0.00168	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.001	0.00168	CbGpPWpGaD
Prazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000995	0.00167	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000984	0.00165	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000973	0.00163	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000972	0.00163	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000966	0.00162	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00095	0.00159	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000949	0.00159	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000937	0.00157	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000936	0.00157	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00093	0.00156	CbGpPWpGaD
Prazosin—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000924	0.00155	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000917	0.00153	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000907	0.00152	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000905	0.00152	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000903	0.00151	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000886	0.00148	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000873	0.00146	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000873	0.00146	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000861	0.00144	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00086	0.00144	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00086	0.00144	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000858	0.00144	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000841	0.00141	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000833	0.00139	CbGpPWpGaD
Prazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000826	0.00138	CbGpPWpGaD
Prazosin—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00082	0.00137	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000801	0.00134	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0008	0.00134	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000797	0.00133	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000777	0.0013	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000777	0.0013	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000776	0.0013	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000774	0.00129	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000772	0.00129	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00075	0.00125	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00075	0.00125	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000744	0.00125	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000737	0.00123	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000737	0.00123	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000735	0.00123	CbGpPWpGaD
Prazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000734	0.00123	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000723	0.00121	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000721	0.00121	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000714	0.00119	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000714	0.00119	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000698	0.00117	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000687	0.00115	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000665	0.00111	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000665	0.00111	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000656	0.0011	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000653	0.00109	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000642	0.00107	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000634	0.00106	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000634	0.00106	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000612	0.00102	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000607	0.00102	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000591	0.000989	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000589	0.000986	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000589	0.000986	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000585	0.000979	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.000582	0.000974	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000568	0.000951	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000561	0.000939	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000553	0.000926	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000549	0.000919	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000547	0.000916	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000543	0.000909	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000531	0.000889	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000529	0.000886	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000516	0.000863	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00051	0.000854	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000507	0.000848	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000505	0.000845	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000504	0.000843	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000501	0.000838	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000489	0.000819	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000486	0.000814	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00048	0.000804	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000466	0.00078	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000455	0.000761	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000453	0.000758	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000452	0.000757	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000441	0.000739	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000439	0.000734	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000436	0.00073	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000424	0.000709	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000416	0.000696	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000414	0.000692	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000411	0.000688	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000411	0.000687	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000409	0.000684	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000403	0.000675	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000402	0.000674	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000399	0.000667	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000396	0.000663	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000395	0.000661	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000385	0.000644	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000384	0.000643	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000377	0.000632	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000376	0.000629	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000371	0.000621	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000371	0.00062	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000369	0.000618	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000366	0.000613	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000358	0.0006	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000358	0.0006	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000343	0.000574	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000341	0.000571	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000337	0.000563	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000335	0.000561	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000334	0.000559	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000333	0.000557	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000325	0.000545	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000317	0.000531	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000314	0.000525	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000311	0.000521	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00031	0.000519	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000305	0.00051	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000303	0.000507	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000302	0.000506	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000299	0.0005	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000288	0.000482	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000286	0.000479	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000284	0.000475	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000282	0.000471	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000276	0.000463	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000269	0.00045	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000263	0.000441	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000261	0.000436	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00026	0.000435	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000251	0.00042	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000243	0.000407	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000242	0.000406	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000239	0.0004	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000235	0.000394	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000234	0.000392	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000234	0.000391	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000227	0.00038	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000223	0.000373	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000219	0.000367	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000217	0.000364	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000216	0.000362	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000212	0.000355	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000212	0.000354	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000202	0.000337	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000199	0.000333	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000198	0.000331	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000197	0.00033	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000192	0.000322	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000184	0.000308	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000179	0.0003	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000179	0.000299	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00017	0.000285	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000166	0.000278	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000154	0.000257	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000148	0.000248	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000141	0.000236	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000125	0.00021	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000117	0.000195	CbGpPWpGaD
